SAM
AUPH icon

Smartleaf Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Smartleaf Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97K Hold
296
– – ﹤0.01% 2684
2026
Q1 		$4.14K Sell
296
-461
-61% -$6.74K ﹤0.01% 2743
2025
Q4 		$12K Buy
757
+17
+2% +$241 ﹤0.01% 2310
2025
Q3 		$8.18K Buy
740
+214
+41% +$2.34K ﹤0.01% 2194
2025
Q2 		$4.54K Buy
526
+298
+131% +$2.39K ﹤0.01% 2085
2025
Q1 		$1.89K Sell
228
-651
-74% -$5.27K ﹤0.01% 2485
2024
Q4 		$8.06K Buy
879
+411
+88% +$3.35K ﹤0.01% 2076
2024
Q3 		$3.41K Buy
+468
New +$2.9K ﹤0.01% 2286

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Smartleaf Asset Management's AUPH Position: Q2 2026 in Review

Smartleaf Asset Management held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 296 shares worth $4.97K. The position accounts for ﹤0.01% of the portfolio, ranked #2684.

Smartleaf Asset Management first reported a position in AUPH in Q3 2024 and has held it in 8 quarters since. The position peaked at $12K in Q4 2025. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Smartleaf Asset Management held 296 shares of Aurinia Pharmaceuticals worth $4.97K as of Q2 2026.
  • Smartleaf Asset Management left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2684 holding.
  • Smartleaf Asset Management first reported a position in Aurinia Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Aurinia Pharmaceuticals position peaked at $12K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.